Paper38457490
Legacy of a magic gene-CCR5-∆32: From discovery to clinical benefit in a generation.
OBrien SJ. Proc Natl Acad Sci U S A, 2024. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Legacy of a magic gene-CCR5-∆32: From discovery to clinical benefit in a generation. Papers, record 38457490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38457490
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| Acquired Immunodeficiency Syndrome | Major topic |
| Humans | |
| Gene Frequency | |
| Receptors, CCR5 | |
| Mutation | |
| Homozygote |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 000000 | NCI-NIH Intramural Program | PubMed |
Source PubMed
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,498,103 | Shock greets claim of CRISPR-edited babies. | Science | 2018 | https://conductscience.org/library/papers/30498103 | PubMed |
| 2 | 6,189,183 | Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). | Science | 1983 | https://conductscience.org/library/papers/6189183 | PubMed |
| 3 | 36,931,242 | HIV-1 remission and possible cure in a woman after haplo-cord blood transplant. | Cell | 2023 | https://conductscience.org/library/papers/36931242 | PubMed |
| 4 | 19,630,558 | Stewardship of human biospecimens, DNA, genotype, and clinical data in the GWAS era. | Annu Rev Genomics Hum Genet | 2009 | https://conductscience.org/library/papers/19630558 | PubMed |
| 5 | 14,645,720 | Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14645720 | PubMed |
| 6 | 22,375,323 | Blocking HIV's attack. | Sci Am | 2012 | https://conductscience.org/library/papers/22375323 | PubMed |
| 7 | 24,157,548 | Genome engineering using the CRISPR-Cas9 system. | Nat Protoc | 2013 | https://conductscience.org/library/papers/24157548 | PubMed |
| 8 | 15,167,933 | Human genes that limit AIDS. | Nat Genet | 2004 | https://conductscience.org/library/papers/15167933 | PubMed |
| 9 | 22,784,116 | Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22784116 | PubMed |
| 10 | 9,621,067 | Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. | J Virol | 1998 | https://conductscience.org/library/papers/9621067 | PubMed |
| 11 | 16,230,476 | Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. | J Exp Med | 2005 | https://conductscience.org/library/papers/16230476 | PubMed |
| 12 | 10,534,150 | Phenotypic expressions of CCR5-delta32/delta32 homozygosity. | J Acquir Immune Defic Syndr | 1999 | https://conductscience.org/library/papers/10534150 | PubMed |
| 13 | 28,132,517 | Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa. | AIDS Res Hum Retroviruses | 2017 | https://conductscience.org/library/papers/28132517 | PubMed |
| 14 | 33,922,579 | HIV-1 Entry and Membrane Fusion Inhibitors. | Viruses | 2021 | https://conductscience.org/library/papers/33922579 | PubMed |
| 15 | 23,235,831 | CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. | Nature | 2013 | https://conductscience.org/library/papers/23235831 | PubMed |
| 16 | 32,558,485 | Genomewide Association Study of Severe Covid-19 with Respiratory Failure. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32558485 | PubMed |
| 17 | 6,200,935 | Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. | Science | 1984 | https://conductscience.org/library/papers/6200935 | PubMed |
| 18 | 30,794,775 | CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury. | Cell | 2019 | https://conductscience.org/library/papers/30794775 | PubMed |
| 19 | 8,658,171 | CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. | Science | 1996 | https://conductscience.org/library/papers/8658171 | PubMed |
| 20 | 19,213,682 | Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19213682 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,797,803 | CCR5 as a Therapeutic Target in HIV Disease: From CRISPR/Cas9 Gene Editing to Maraviroc-Mediated Inhibition. | Viruses | 2026 | https://conductscience.org/library/papers/42797803 | PubMed |
| 42,797,766 | Emerging CCR5-Based Therapeutic Potential of JAK/STAT Inhibitors and CCR5Δ32 Hematopoietic Stem Cell Transplantation. | Viruses | 2026 | https://conductscience.org/library/papers/42797766 | PubMed |
| 41,941,864 | Genetic insights into the peoples who shaped the American continent. | Genet Mol Biol | 2026 | https://conductscience.org/library/papers/41941864 | PubMed |
| 41,808,988 | Integrative multiomics analysis and CRISPR screening identify functional noncanonical translation loci in the mouse immune system. | bioRxiv | 2026 | https://conductscience.org/library/papers/41808988 | PubMed |
| 41,535,498 | The infection enigma: why some people die from typically harmless germs. | Nature | 2026 | https://conductscience.org/library/papers/41535498 | PubMed |
| 41,301,743 | The Role of the CCR5 Receptor in Neuropathic Pain Modulation: Current Insights and Therapeutic Implications. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301743 | PubMed |
| 40,149,913 | Deep Thought on the HIV Cured Cases: Where Have We Been and What Lies Ahead? | Biomolecules | 2025 | https://conductscience.org/library/papers/40149913 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCR5 | 1,234 | PubTator's text mining | https://conductscience.org/library/genes/1234 | NCBI Gene |
| CXCR4 | 7,852 | PubTator's text mining | https://conductscience.org/library/genes/7852 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38457490
GET https://conductscience.org/api/papers/v1/38457490/references?page=2